Format

Send to

Choose Destination
Clin Pharmacol Ther. 2016 Jul;100(1):63-6. doi: 10.1002/cpt.347. Epub 2016 Mar 31.

Implementation of a pharmacogenomics consult service to support the INGENIOUS trial.

Author information

1
Department of Medicine, Indiana University, Indianapolis, Indiana, USA.
2
Department of Medical and Molecular Genetics, Indiana University, Indianapolis, Indiana, USA.
3
Department of Veterans Affairs, Indianapolis, Indiana, USA.
4
Department of Pediatrics, Northwestern University, Chicago, Illinois, USA.
5
School of Nursing, Indiana University, Indianapolis, Indiana, USA.
6
Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA.
7
Department of Obstetrics and Gynecology, Indiana University, Indianapolis, Indiana, USA.
8
Regenstrief Institute for Health Care, Indiana University, Indianapolis, Indiana, USA.

Abstract

Hospital systems increasingly utilize pharmacogenomic testing to inform clinical prescribing. Successful implementation efforts have been modeled at many academic centers. In contrast, this report provides insights into the formation of a pharmacogenomics consultation service at a safety-net hospital, which predominantly serves low-income, uninsured, and vulnerable populations. The report describes the INdiana GENomics Implementation: an Opportunity for the UnderServed (INGENIOUS) trial and addresses concerns of adjudication, credentialing, and funding.

PMID:
26850569
PMCID:
PMC4899152
DOI:
10.1002/cpt.347
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center